Contact
Please use this form to send email to PR contact of this press release:
Royalty report for Q2 2016 and update on lixisenatide (Lyxumia(r)/AdlyxinTM) and iGlarLixi
TO:
Please use this form to send email to PR contact of this press release:
Royalty report for Q2 2016 and update on lixisenatide (Lyxumia(r)/AdlyxinTM) and iGlarLixi
TO: